Notably, L-selectin overexpression in mice allowed for equivalent tumor infiltration and improved anti-tumor function of CAR-T cells by decreasing the activation threshold of the transferred cells, contrary to the presumed improvement in lymphoid organ homing. The gene discussed is SELL; the disease is neoplasm.